Navigation Links
Graymark Healthcare, Inc. to Host Conference Call to Discuss Q2 Financial Results
Date:8/3/2010

OKLAHOMA CITY, Aug. 3 /PRNewswire-FirstCall/ -- Graymark Healthcare, Inc. (Nasdaq: GRMH) will host a conference call at 10:00 am CDT on Tuesday, August 10, 2010, to discuss the company's financial results for Q2, 2010. Management will review the second quarter financial results and provide an update on the company.

The conference call will be webcast on the investor relations section of Graymark's website at http://www.graymarkhealthcare.com/ or may be accessed by dialing 1-866-783-2143 for domestic callers and 1-857-350-1602 for International callers. The conference call ID number is 20777534.

A replay of the conference call will be available from 1:00 p.m. CDT on Tuesday, August 10, 2010, through 11:59 p.m. CDT on Friday, September 10, 2010, and may be accessed by visiting Graymark's website or by dialing 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The replay access code is 70156562.

About Graymark Healthcare

Graymark Healthcare, Inc. is a diversified medical holding company that owns and operates diagnostic sleep centers that treat a wide range of sleep disorders; independent pharmacies that serve the needs of local markets; and a medical equipment company that provides both dis
'/>"/>

SOURCE Graymark Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Graymark Healthcare Sells Record Number of CPAP Devices in Q2 2010
2. Americans Losing Confidence in Their Ability to Access and Pay for Healthcare, According to Thomson Reuters Index
3. Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty
4. D-M-S Holdings, Inc. Announces the Filing of a Lawsuit Against Veridian Healthcare, LLC, Steven M. Bisulca and Michael Mazza
5. Medco, State of Illinois and Community Retail Pharmacies Launch Wired Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs
6. Onyx Pharmaceuticals to Present at the Canaccord Genuity 30th Annual Growth Conference
7. Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast
8. Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2010 Earnings Release Date and Teleconference
9. Accuray Incorporateds CEO to Speak at BMO Capital Markets Tenth Annual Focus on Healthcare Conference
10. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
11. Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  SurgiQuest®, Inc. ("SurgiQuest", ... technologies for minimally invasive surgery (MIS) announced today ... in over 250,000 procedures.  Adoption has risen rapidly ... last year, driven by the company,s expansion from ... as geographic expansion to over 45 countries.   ...
(Date:6/3/2015)... 02, 2015 Research and Markets  ( ... "Global Neurodegenerative Diseases Market 2015-2019" report ... diseases market to grow at a CAGR of ... report covers the present scenario and the growth ... the period 2015-2019. To calculate the market size, ...
(Date:6/3/2015)... CAMBRIDGE, Mass. , June 3, 2015  EIP ... dosing in phase 2 clinical development of VX-745 in ... brain penetrant, highly selective and potent inhibitor of the ... protein kinase (p38 MAPK alpha). "Recent human ... of disease in patients with symptomatic Alzheimer,s, while the ...
Breaking Medicine Technology:Rapid Procedure Growth With SurgiQuest's AirSeal System 2Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... 2011 Eli Lilly and Company (NYSE: ... December 31 retirements of longtime senior leaders, Bryce D. Carmine ... spans 36 years, has led Lilly Bio-Medicines since its creation ... years, has led global manufacturing operations since 2007. Previously, both ...
... Fusion, the fastest growing EMR community in the US, ... 2011, is sold out.  Held at the Masonic Center ... will feature keynote speakers including Ryan Howard, Peter Thiel, ... National Coordinator for Health Information Technology with the Department ...
Cached Medicine Technology:Lilly Announces Changes in Senior Management 2Lilly Announces Changes in Senior Management 3Lilly Announces Changes in Senior Management 4Practice Fusion Connect 2011, the Health Tech Event of the Year 2Practice Fusion Connect 2011, the Health Tech Event of the Year 3Practice Fusion Connect 2011, the Health Tech Event of the Year 4
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... 03, 2015 VeoMed and Decker ... online and mobile access to premier Continuing Medical ... of Certification (MOC) activities. , ... courses to Decker’s extensive lists of physicians, residents, ... access to VeoMed’s premier online and live-streamed courses. ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Visual ... Analytics solutions, today announced the launch of the ... (DSX) for SAP® BusinessObjects™ Design Studio. The Design ... visualization capabilities and advanced functionalities into their dashboarding ... DSX suite, Visual BI is adding key components ...
(Date:6/3/2015)... 2015 According to an article published ... intercepted fake oxycodone pills which actually contained the potent ... look legitimate, and even sported the “A/215” imprint common ... consuming 30 mg oxycodone to be exceptionally critical of ... buy them illegally on the street. Fentanyl is an ...
(Date:6/3/2015)... These are challenging and unpredictable times for traditional organizations ... business are rewriting the rules for business as we ... traditional businesses to take on a more agile approach ... On top of this there is a growing ... bring new innovation and approaches to business. , The ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2
... Despite initiatives, level of diversity among faculty, practitioners still ... say , ANN ARBOR, Mich. , Jan. ... medical school faculty remains low, even as the U.S. population ... currently being trained in medicine is unlikely to reverse those ...
... , Jan. 28 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... in 2010. Each of the dividends will be $0.50 per share. ... to all stockholders who own shares of PDL on March 15, 2010 ... October 1, 2010 to all stockholders who own shares of PDL on ...
... , ... of Hematology (ASH) now offers physicians who diagnose and treat ... (CME) credits while staying abreast of the latest clinical strategies ... with Medscape, an online network of medical content for physicians ...
... , BRIGHTON, Mich. , ... alcohol and drug treatment provider in North America, has signed a ... a Saudi Arabian company to build a 291,000 square-foot, 250 ... the entire Islamic Mideast. , Brighton Hospital, the Addiction Treatment ...
... for ovarian cancer does not appear to detect early-stage ovarian ... 1 out of 100 women in the general population with ... in the Journal of the National Cancer Institute . ... in Seattle assessed the predictive value of certain symptoms, including ...
... vaccine developed using non-infectious virus-like particles (VLP) has ... mosquito-borne pathogen that has infected millions of people ... researchers at the National Institutes of Health have ... Allergy and Infectious Diseases (NIAID) developed the vaccine ...
Cached Medicine News:Health News:More Recruiting of Underrepresented Minorities Needed at U.S. Medical Schools, Study Says 2Health News:More Recruiting of Underrepresented Minorities Needed at U.S. Medical Schools, Study Says 3Health News:PDL BioPharma Announces Two $0.50 Dividends in 2010 2Health News:Hematologists Can Now Earn CME Credits Through the Journal Blood 2Health News:Hematologists Can Now Earn CME Credits Through the Journal Blood 3Health News:St. John Health System Brighton Hospital Signs Letter of Intent to Assist Saudi Arabia in Developing New Addiction Treatment Hospital in Riyadh 2Health News:St. John Health System Brighton Hospital Signs Letter of Intent to Assist Saudi Arabia in Developing New Addiction Treatment Hospital in Riyadh 3Health News:St. John Health System Brighton Hospital Signs Letter of Intent to Assist Saudi Arabia in Developing New Addiction Treatment Hospital in Riyadh 4Health News:Symptoms have little value for early detection of ovarian cancer 2Health News:Virus-like particle vaccine protects monkeys from chikungunya virus 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: